Bladder Cancer Research

Clinical Trials for Recurrent Bladder Cancer

The evaluation and treatment of bladder cancer is a complex process that typically involves multiple procedures and care providers.  Dr. Paul Crispen’s research aims to improve the care of all stages of bladder cancer through clinical and basic science research.

Need: funding to support for recruitment and treatment of patients with resistant bladder cancer

Involved Faculty: Paul Crispen, MD, Padriac O’Malley, MD, Sergei Kusmartsev, PhD

Click here to learn more about Bladder Cancer Research

Ranked as the #32 urology program in the nation by U.S. News & World Report